1 |
Bingol B, Tea JS, Phu L et al (2014) The mitochondrial deubiquitinase USP30 opposes Parkin-mediated mitophagy. Nature 510, 370-375
DOI
|
2 |
Cornelissen T, Haddad D, Wauters F et al (2014) The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. Hum Mol Genet 23, 5227-5242
DOI
|
3 |
Chakraborty J, von Stockum S, Marchesan E et al (2018) USP14 inhibition corrects an in vivo model of impaired mitophagy. EMBO Mol Med 10, e9014
DOI
|
4 |
Obergasteiger J, Frapporti G, Lamonaca G et al (2020) Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions. Cell Death Discov 6, 1-13
|
5 |
Safiulina D, Kuum M, Choubey V et al (2019) Miro proteins prime mitochondria for Parkin translocation and mitophagy. EMBO J 38, e99384
DOI
|
6 |
Durcan TM, Tang MY, Perusse JR et al (2014) USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. EMBO J 33, 2473-2491
DOI
|
7 |
Um JH and Yun JH (2017) Emerging role of mitophagy in human diseases and physiology. BMB Rep 50, 299
DOI
|
8 |
Henderson MX, Trojanowski JQ and Lee VMY (2019) α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies. Neurosci Lett 709, 134316
DOI
|
9 |
Ryan BJ, Hoek S, Fon EA and Wade-Martins R (2020) Mitochondrial dysfunction and mitophagy in Parkinson's disease: from mechanism to therapy. Trends Biochem Sci 40, 200-210
DOI
|
10 |
Wang W, Wang X, Fujioka H et al (2016) Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat Med 22, 54-63
DOI
|
11 |
Palikaras K, Lionaki E and Tavernarakis N (2018) Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol 20, 1013-1022
DOI
|
12 |
Nijman SM, Luna-Vargas MP, Velds A et al (2015) Genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786
DOI
|
13 |
Chakraborty J and Ziviani E (2020) Deubiquitinating enzymes in Parkinson's disease. Front Physiol 11, 535
DOI
|
14 |
Tanik SA, Schultheiss CE, Volpicelli-Daley LA, Brunden KR and Lee VM (2013) Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy. J Biol Chem 288, 15194-15210
DOI
|
15 |
Rott R, Szargel R, Haskin J et al (2011) α-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc Proc Natl Acad Sci U S A 108, 18666-18671
DOI
|
16 |
Hirota Y, Yamashita S, Kurihara Y et al (2015) Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy 11, 332-343
DOI
|
17 |
Faesen AC, Luna-Vargas MP and Geurink PP (2011) The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types. Chem Biol 18, 1550-1561
DOI
|
18 |
Chinta SJ, Mallajosyula JK, Rane A and Andersen JK (2010) Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 486, 235-239
DOI
|
19 |
Narendra DP, Jin SM, Tanaka A et al (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8, e1000298
DOI
|
20 |
McLelland GL, Soubannier V, Chen CX, McBride HM and Fon EA (2014) Parkin and PINK 1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J 33, 282-295
DOI
|
21 |
Liu Y, Ma X, Fujioka H, Liu J, Chen S and Zhu X (2019) DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1. Proc Natl Acad Sci U S A 116, 25322-25328
DOI
|
22 |
Zhang Y, Gong XG, Wang ZZ et al (2016) Overexpression of DJ-1/PARK7, the Parkinson's disease-related protein, improves mitochondrial function via Akt phosphorylation on threonine 308 in dopaminergic neuron-like cells. Eur J Neurosci 43, 1379-1388
DOI
|
23 |
Thomas KJ, McCoy MK, Blackinton J et al (2011) DJ-1 acts in parallel to the PINK1/Parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet 20, 40-50
DOI
|
24 |
Walter J, Bolognin S, Antony PM et al (2019) Neural stem cells of Parkinson's disease patients exhibit aberrant mitochondrial morphology and functionality. Stem Cell Reports 12, 878-889
DOI
|
25 |
Lonskaya I, Desforges NM, Hebron ML and Moussa CE (2013) Ubiquitination increases parkin activity to promote autophagic α-synuclein clearance. PLoS One 8, e83914
DOI
|
26 |
Liu X, Hebron M, Shi W, Lonskaya I and Moussa CE (2019) Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies. Hum Mol Genet 28, 548-560
DOI
|
27 |
Devi L, Raghavendran V, Prabhu BM, Avadhani NG and Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283, 9089-9100
DOI
|
28 |
Ferrucci M, Pasquali L, Ruggieri S, Paparelli A and Fornai F (2008) Alpha-synuclein and autophagy as common steps in neurodegeneration. Parkinsonism Relat Disord 14, S180-S184
DOI
|
29 |
Reyes-Turcu FE, Ventii KH and Wilkinson KD (2019) Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 78, 363-397
DOI
|
30 |
Marella M, Seo BB, Yagi T and Matsuno-Yagi A (2009) Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy. J Bioenerg Biomembr 41, 493-497
DOI
|
31 |
Bishop P, Rocca D and Henley JM (2016) Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction. Biochem J 473, 2453-2462
DOI
|
32 |
Liu J, Liu W, Li R and Yang H (2019) Mitophagy in Parkinson's disease: From pathogenesis to treatment. Cells 8, 712
DOI
|
33 |
Rojas-Charr L, Cookson MR, Nino A, Arboleda H and Arboleda G (2014) Downregulation of PINK1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells. Neurotoxicology 44, 140-148
DOI
|
34 |
Dixon C, Mathias N, Zweig RM, Davis DA and Gross DS (2005) Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics 170, 47-59
DOI
|
35 |
Swatek KN and Komander D (2016) Ubiquitin modifications. Cell Res 26, 399-422
DOI
|
36 |
Vicario M, Cieri D, Brini M and Cali T (2018) The close encounter between alpha-synuclein and mitochondria. Front Neurosci 12, 1-13
DOI
|
37 |
Kane LA, Lazarou M, Fogel AI et al (2014) PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol 205, 143-153
DOI
|
38 |
Eiyama A and Okamoto K (2015) PINK1/Parkin-mediated mitophagy in mammalian cells. Curr Opin Cell Biol 33, 95-101
DOI
|
39 |
Guhathakurta S, Kim J, Adams L et al (2021) Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson's disease. EMBO Mol Med 13, e12188
|
40 |
Shen J, Du T, Wang X et al (2014) α-Synuclein amino terminus regulates mitochondrial membrane permeability. Brain Res 1591, 14-26
DOI
|
41 |
Berenguer-Escuder C, Grossmann D, Massart F et al (2019) Variants in Miro1 cause alterations of ER-mitochondria contact sites in fibroblasts from Parkinson's disease patients. J Clin Med 8, 2226
DOI
|
42 |
Bonello F, Hassoun SM, Mouton-Liger F et al (2019) LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease. Hum Mol Genet 28, 1645-1660
DOI
|
43 |
Yakhine-Diop SM, Niso-Santano M and Rodriguez-Arribas M (2019) Impaired mitophagy and protein acetylation levels in fibroblasts from Parkinson's disease patients. Mol Neurobiol 56, 2466-2481
DOI
|
44 |
De Snoo ML, Friesen EL, Zhang YT et al (2019) Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death. Cell Death Dis 10, 907
DOI
|
45 |
Wang X, Guo J, Fei E et al (2014) BAG5 protects against mitochondrial oxidative damage through regulating PINK1 degradation. PLoS One 9, e86276
DOI
|
46 |
Grossmann D, Berenguer-Escuder C, Chemla A, Arena G and Kruger R (2020) The emerging role of RHOT1/Miro1 in the pathogenesis of Parkinson's disease. Front Neurol 11, 587
DOI
|
47 |
Birsa N, Norkett, R, Wauer T et al (2014) Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase. J Biol Chem 289, 14569-14582
DOI
|
48 |
Polymeropoulos MH (1998) Autosomal dominant Parkinson's disease and alpha-synuclein. Ann Neurol 44, S63-64
DOI
|
49 |
Todi SV and Paulson HL (2011) Balancing act: deubiquitinating enzymes in the nervous system. Trends Neurosci 34, 370-382
DOI
|
50 |
Magraoui FE, Reidick C, Meyer HE and Platta HW (2015) Autophagy-related deubiquitinating enzymes involved in health and disease. Cells 4, 596-621
DOI
|
51 |
Alexopoulou Z, Lang J, Perrett RM et al (2016) Deubiquitinase USP8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease. Proc Natl Acad Sci U S A 113, E4688-E4697
|
52 |
Shaid S, Brandts CH, Serve H and Dikic I (2013) Ubiquitination and selective autophagy. Cell Death Differ 20, 121-130
|
53 |
Joselin AP, Hewitt SJ, Callaghan SM et al (2012) ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons. Hum Mol Genet 21, 4888-4903
DOI
|
54 |
Tan T, Zimmermann M and Reichert AS (2016) Controlling quality and amount of mitochondria by mitophagy: insights into the role of ubiquitination and deubiquitination. Biol Chem 397, 637-647
DOI
|
55 |
Heo JM, Ordureau A, Paulo JA, Rinehart J and Harper JW (2015) The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell 60, 7-20
DOI
|
56 |
Lin MT and Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795
DOI
|
57 |
Devoto VT and Falzone TL (2017) Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein. Dis Model Mech 10, 1075-1087
DOI
|
58 |
Qu D, Hage A, Don-Carolis K et al (2015) BAG2 gene-mediated regulation of PINK1 protein is critical for mitochondrial translocation of PARKIN and neuronal survival. J Biol Chem 290, 30441-30452
DOI
|
59 |
Durcan TM and Fon EA (2015) The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes Dev 29, 989-999
DOI
|
60 |
Carballo-Carbajal I, Weber-Endress S, Rovelli G et al (2010) Leucine-rich repeat kinase 2 induces α-synuclein expression via the extracellular signal-regulated kinase pathway. Cell Signal 22, 821-827
DOI
|
61 |
Kalia SK, Lee S, Smith PD et al (2004) BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron 44, 931-945
DOI
|
62 |
Sugiura A, McLelland GL, Fon EA and McBride HM (2014) A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J 33, 2142-2156
DOI
|
63 |
Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT and Sulzer D (2004) Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy. Science 305, 1292-1295
DOI
|
64 |
Thomas KJ, McCoy MK, Blackinton J et al (2011) DJ-1 acts in parallel to the PINK1/Parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet 20, 40-50
DOI
|
65 |
Thomas HE, Zhang Y, Stefely JA et al (2018) Mitochondrial complex I activity is required for maximal autophagy. Cell Rep 24, 2404-2417
DOI
|
66 |
Hao LY, Giasson BI and Bonini NM (2010) DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc Natl Acad Sci U S A 107, 9747-9752
DOI
|
67 |
Wang Y, Serricchio M, Jauregui M et al (2015) Deubiquitinating enzymes regulate PARK2-mediated mitophagy. Autophagy 11, 595-606
DOI
|
68 |
Niu K, Fang H, Chen Z et al (2020) USP33 deubiquitinates PRKN/Parkin and antagonizes its role in mitophagy. Autophagy 16, 724-734
DOI
|
69 |
Wang L, Qi H, Tang Y, Shen HM (2020) Post-translational modifications of key machinery in the control of mitophagy. Trends Biochem Sci 45, 58-75
DOI
|
70 |
Kabuta T, Furuta A, Aoki S, Furuta K and Wada K (2008) Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J Biol Chem 283, 23731-23738
DOI
|
71 |
Carmine Belin A, Westerlund M, Bergman O et al (2007) S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden. Parkinsonism Relat Disord 13, 295-298
DOI
|